The effect of antitumor trans-[PtCl2(E-iminoether)2] on B→Z transition in DNA

Anti-Cancer Drug Design

Volumn 12, Issue 4, 1997, Pages 295-309

  Zaludova R ^a   Natile, G ^b   Brabec, V ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Antitumor activity; Circular dichroism; DNA conformation poly(dG dC) poly(dG dC); Platinum drugs; Raman spectroscopy

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; PLATINUM COMPLEX; TRANSPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CIRCULAR DICHROISM; CIS ISOMER; CONFORMATIONAL TRANSITION; DNA CONFORMATION; PRIORITY JOURNAL; RAMAN SPECTROMETRY;

ANTIBODY AFFINITY; BINDING, COMPETITIVE; CISPLATIN; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; NUCLEIC ACID CONFORMATION; SPECTRUM ANALYSIS, RAMAN; STEREOISOMERISM;

EID: 0030957979     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BANCROFT, D.P., LEPRE, C.A. & LIPPARD, S J. (1990). 195Pt NMR kinetic and mechanistic studies of cis-and trans-diamminedichloroplatinum(II) binding to DNA. Journal of the American Chemical Society, 112, 6860.
2. BARRY, M A., BEHNKE, C.A. & EASTMAN, A. (1990). Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochemical Pharmacology, 40, 2353.
3. BRABEC, V., KLEINWÃCHTER, V., BUTOUR, J.L. & JOHNSON, NP (1990). Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. Biophysical Chemistry, 35, 129.
4. BRABEC, V., VRÁNA, O., KISELEVA, V.I & POVERENNY, A.M. (1991). Polyclonal antibodies elicited against trans-diamminedichloropiatinum(II)-modified DNA and their application in non radioactive hybridization experiments. European Journal of Biochemistry, 201, 723.
5. BRABEC, V., REEDIJK, J. & LENG, M. (1992). Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding. Biochemistry, 31, 12397.
6. BRABEC, V., BOUDNÝ, V. & BALCAROVÁ, z. (1994). Monofunctional adducts of platinum(II) produce in DNA a sequence-dependent local denaturation. Biochemistry, 32, 1316.
7. 2]. Nucleic Acids Research, 24, 336.
8. CINI, R , CAPUTO, P.A., INTINI, F P. & NATILE, G. (1995). Mechanistic and stereochemical investigation of iminoethers formed by alcoholysis of coordinated nitrils: X-ray crystal structure of cis- and trans-[bis(1-imino-1-methoxyethane) dichloroplatinum (II)]. Inorganic Chemistry, 34, 1130.
9. COLUCCIA, M , NASSII, A , LOSETO, F., BOCCARELLI, A., MARIGGIO, M.A., GIORDANO, D., INTINI, F.P., CAPUTO, P. & NATILE, G. (1993). A trans-platinum complex showing higher antitumor activity than the congeners. Journal of Medicinal Chemistry, 36, 510.
10. COLUCCIA, M., BOCCARELLI, A., MARIGGIO, M A., CARDELLICCHIO, N, CAPUTO, P., INTINI, F P. & NATILE, G. (1995). Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent. Chemico-Biological Interactions, 98, 251.
11. EASTMAN, A. (1987). The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacological Therapy, 34, 155.
12. FARRELL, N (1996). Current status of structure-activity relationships of platinum anticancer drugs: Activation of the trans geometry. In Metal Ions in Biological Systems. Sigel, A, & Sigel, H. (eds), p. 603. Marcel Dekker, Inc.: New York.
13. FARRELL, N., KELLAND, L.R., ROBERTS, J.D. & VAN BEUSICHEM, M. (1992). Activation of the trans geometry in platinum antitumor complexes. A survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action. Cancer Research, 52, 5065.
14. GODDARD, P.M., ORR, R M., VALENTI, M.R., BARNARD, C.F.J, MURRER, B.A , KELLAND, L.R. & HARRAP, K.R. (1996). Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Anticancer Research, 16, 33.
15. JOHNSON, N.P., MACQUET, JP, WIEBERS, J.L & MONSARRAT, B. (1982). Structures of adducts formed between [Pt(dien)Cl]Cl and DNA in vitro. Nucleic Acids Research, 10, 5255.
16. JOHNSON, N.P., BUTOUR, J.-L , VILLANI, G., WIMMER, F.L., DEFAIS, M, PIERSON, V. & BRABEC, V. (1989). Metal antitumor compounds: the mechanism of action of platinum complexes. Progress in Clinical Biochemistry and Medicine, 10, 1.
17. KELLAND, L.R., BARNARD, C.F.J., EVANS, I.G, MURRER, B.A., THEOBALD, B.R.C , WYER, S.B., GODDARD, P.M., JONES, M., VALENTI, M., BRYANT, A., ROGERS, P.M. & MARRA, KR (1995). Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes. Journal of Medicinal Chemistry, 38, 3016.
18. KIM, SD., VRÁNA, O., KLEINWÄCHTER, V., NIKI, K & BRABEC, V. (1990). Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA. Analytical Letters, 23, 1505.
19. KISELEVA, V.I & POVERENNY, A M. (1988). Immunoenzymatic method to study lefthanded DNA. Molecular Biology (English Translation), 21, 1265.
20. LENG, M. & BRABEC, V (1994). DNA adducts of cisplatin, transplatin and platinum intercalating drugs. In DNA Adducts: Identification and Biological Significance, Hemminki, K., Dipple, A., Shuker, D.E.G., Kladlubar, F.F., Segerback, D.,& Bartsch, H. (eds), p. 339. IARC Scientific Publications No. 125, International Agency for Research on Cancer, Lyon.
21. LEPRE, C.A. & LIPPARD, S.J (1990). Interaction of platinum antitumor compounds with DNA. Nucleic Acids and Molecular Biology, 4, 9.
22. LOEHRER, PJ & EINHORN, L.H. (1984). Cisplatin. Annals of Internal Medicine, 100, 704.
23. MALFOY, B. & LENG, M. (1981). Antiserum to Z-DNA. FEBS Letters, 132, 45.
24. MALFOY, B., HARTMANN, B. & LENG, M. (1981). The B→Z transition of poly(dG-dC):poly(dG-dC) modified by some platinum derivatives. Nucleic Acids Research, 9, 5659.
25. MALINGE, J.M. & LENG, M. (1984). Reaction of cis-diamminedichloroplatinum(II) and DNA in B and Z conformation. The EMBO Journal, 3, 1273.
26. MALINGE, J.M., PTAK, M. & LENG, M. (1984). Immunological and spectroscopic studies of poly(dG-dC):poly(dG-dC) modified by cis-diamminedichloroplatinum(II). Nucleic Acids Research, 12, 5767.
27. MOLLER, A., NORDHEIM, A., KOZLOWSKI, S.A., PATEL, D.J & RICH, A. (1984). Bromination stabilizes poly(dG-dC) in the Z form under low-salt conditions. Biochemistry, 23, 54.
28. ORMEROD, M.G., O'NEILL, C. ROBERTSON, D., KELLAND, L.R. & HARRAP, K R. (1996). Cis-Diammine-dichloroplatinum(II) induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemotherapy and Pharmacology, 37, 463.
29. PÉREZ-MARTIN, J.M , REQUENA, J. M., CRACIUNESCU, D, LÓPEZ, M.C. & ALONSO, C. (1993). The anti Z-DNA reactivity of Z-DNA forming sequences is affected by platinum antitumor drugs. Journal of Biological Chemistry, 268, 24774.
30. PETICOLAS, W.L. & THOMAS, G.A (1985a). Rotational isomerism in molecules of genetic interest. Journal of Molecular Structure, 126, 509.
31. PETICOLAS, W.L & THOMAS, GA. (1985b). Flexibility and base composition dependence of DNA conformation in solution from laser Raman scattering. In Structure & Motion: Membranes, Nucleic Acids & Proteins, Clementi, E. Corongiu, G., Sarma, M.H. & Sarma, R.H. (eds), p. 497. Adenine Press: New York.
32. POHL, F.M. &, JOVIN, T.M. (1972). Salt-induced cooperative conformational change of a synthetic DNA: equilibrium and kinetic studies with poly(dG-dC). Journal of Molecular Biology, 67, 375.
33. QUADRIFOGLIO, F., MANZINI, G, VASSER, M., DINKELSPIEL, K & CREA, R. (1981). Conforrnational stability of alternating d(CG) oligomers in high salt solution. Nucleic Acids Research, 9, 2195.
34. RAHMOUNI, A., MALINGE, J.M, SCHWARTZ, A. & LENG, M, (1985). Comparison between poly(dG-dC):poly(dG-dC) and DNA modified by cis-diamminedichloroplatinum(II)-immunological and spectroscopic studies. Journal of Biomolecular Structure and Dynamics, 3, 363.
35. SUNDQUIST, W.I., LIPPARD, S.J. & STOLLAR, B D. (1987). Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II). Proceedings of the National Academy of Sciences, USA, 84, 8225.
36. THOMAS, M.J, & STROBL, J.S. (1988). Enzyme-linked immunosorbent assays for Z-DNA. Biochemical Journal, 255, 53.
37. USHAY, H M , SANTELLA, R.M , CARADONNA, J.P, GRUNBERGER, D. & LIPPARD, SJ (1982). Binding of [(dien)PtCl]Cl to poly(dG-dC)-poly(dG-dC) facilitates the B→Z conformational transition. Nucleic Acids Research, 10, 3573.
38. 2-ethanol, is biologically active. The EMBO Journal, 1, 115.
39. VRÁNA, O., KISELEVA, VI., POVERENNY, A.M. & BRABEC, V. (1992). Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II) - immunochemical analysis. European Journal of Pharmacology - Molecular Pharmacology Section, 226, 5.